(Q43724663)

26 November 2017

Estrogenic activity of two standardized red clover extracts (Menoflavon) intended for large scale use in hormone replacement therapy (English)

1 reference

26 November 2017

4

1 reference

26 November 2017

6

1 reference

26 November 2017

Dornstauder E

1

1 reference

26 November 2017

Jisa E

series ordinal

2

1 reference

26 November 2017

Unterrieder I

series ordinal

3

1 reference

26 November 2017

Kubelka W

series ordinal

5

1 reference

26 November 2017

1 July 2001

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

26 November 2017

1 reference

26 November 2017

78

1 reference

26 November 2017

1

1 reference

26 November 2017

67-75

1 reference

Factors associated with early menopause

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Osteoporosis: prevention with estrogens in women over 60.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Post-menopausal osteoporosis and estrogens. Who should be treated and why

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Update on cancer control in women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Monitoring of estrogen mimics by a recombinant yeast assay: synergy between natural and synthetic compounds?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

A specific breeding problem of sheep on subterranean clover pastures in Western Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Phytoestrogens: the "natural" selective estrogen receptor modulators?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Phytoestrogen content of foods--a compendium of literature values

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Estrogen and progestin bioactivity of foods, herbs, and spices

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Bioavailability of soybean isoflavones depends upon gut microflora in women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Exposure of infants to phyto-oestrogens from soy-based infant formula

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Dietary isoflavones: biological effects and relevance to human health

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Soy protein, isoflavones and cardiovascular disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Genistein, a dietary-derived inhibitor of in vitro angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Antioxidant and antipromotional effects of the soybean isoflavone genistein.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Antioxidant activity of phytoestrogenic isoflavones

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Effects of mammalian and plant estrogens on mammary glands and uteri of macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Human estrogen receptor regulation in a yeast model system and studies on receptor agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Ubiquitin fusion augments the yield of cloned gene products in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Agonistic and synergistic activity of tamoxifen in a yeast model system

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Regulation of human estrogen receptor by phytoestrogens in yeast and human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Phytoestrogens and cardiovascular health.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900075-9

7 January 2021

10.1016/S0960-0760(01)00075-9

Identifiers

DOI

1 reference

26 November 2017

1 reference